Table 3.
Predictive factors of pCR/0 according to the multivariate logistic regression model
| Variables | pCR/0 | |
|---|---|---|
| OR (95% CI) | P value | |
| Molecular subclasses | ||
| HER2+, ER−, PgR−* versus HER2+, ER+ and/or PgR+° | 4.03 (1.85–8.74) | <0.0001 |
| Trastuzumab duration in NST | ||
| >12 weeks versus ≤12 weeks | 2.40 (1.10–5.22) | 0.03 |
HER2 Human epidermal growth factor type 2, ER estrogen receptors, PgR progesteron receptors, OR odds ratio, CI confidence intervals
° Luminal B/HER2+, * nonluminal/HER2+